Related references
Note: Only part of the references are listed.Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy
Beatrice Setnik et al.
SLEEP (2020)
Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment A Randomized Trial
Yves Dauvilliers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
Yves Dauvilliers et al.
SLEEP (2019)
Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis
Adam V. Benjafield et al.
LANCET RESPIRATORY MEDICINE (2019)
Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3) A Randomized Controlled Trial
Paula K. Schweitzer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Solriamfetol for the Treatment of Excessive Sleepiness in OSA A Placebo-Controlled Randomized Withdrawal Study
Patrick J. Strollo et al.
CHEST (2019)
Minimum important difference of the Epworth Sleepiness Scale in obstructive sleep apnoea: estimation from three randomised controlled trials
Sarah Crook et al.
THORAX (2019)
Effects of CPAP and mandibular advancement device treatment in obstructive sleep apnea patients: a systematic review and meta-analysis
Martha Schwartz et al.
SLEEP AND BREATHING (2018)
The Epworth Sleepiness Scale: Minimum Clinically Important Difference in Obstructive Sleep Apnea
Suhani Patel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Challenges in obstructive sleep apnoea
Walter T. McNicholas et al.
LANCET RESPIRATORY MEDICINE (2018)
Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial
Zoltan Szakacs et al.
LANCET NEUROLOGY (2017)
Reviewing the relationship between OSA and cognition: Where do we go from here?
Romola S. Bucks et al.
RESPIROLOGY (2017)
Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis
Julia L. Chapman et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Residual Daytime Sleepiness in Obstructive Sleep Apnea After Continuous Positive Airway Pressure Optimization Causes and Management
Julia L. Chapman et al.
SLEEP MEDICINE CLINICS (2016)
Sleep apnoea and the brain: a complex relationship
Ivana Rosenzweig et al.
LANCET RESPIRATORY MEDICINE (2015)
Comparison of the effects of continuous positive airway pressure and mandibular advancement devices on sleepiness in patients with obstructive sleep apnoea: a network meta-analysis
Daniel J. Bretton et al.
LANCET RESPIRATORY MEDICINE (2015)
Obstructive sleep apnoea syndrome
Patrick Levy et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with Modafinil
M. Uguen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure
Merce Gasa et al.
JOURNAL OF SLEEP RESEARCH (2013)
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
Yves Dauvilliers et al.
LANCET NEUROLOGY (2013)
Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms
C. Vernet et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study
J-L. Pepin et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Share Paper
